ImmunoMet Therapeutics Patents – Insights & Stats (Updated 2023)
ImmunoMet Therapeutics has a total of 100 patents globally, out of which 67 have been granted. Of these 100 patents, more than 79% patents are active. Parallelly, Korea (South) seems to be the main focused R&D centre and also United States Of America is the origin country of ImmunoMet Therapeutics.